Iridex Corp. announced the launch of www.treatmydme.com, an educational website benefiting patients with diabetic macular edema (DME). The website provides information on MicroPulse Laser Therapy, a new treatment option for DME patients. It explains DME, describes MicroPulse Laser Therapy, and addresses patients' expectations before, during, and after treatment. Patients, physicians, and industry specialists are invited to visit www.treatmydme.com for more information.
“The website's launch will facilitate increased patient awareness and education on MicroPulse Laser Therapy as a viable option for the treatment of DME,” commented Dr. Sam Mansour, Medical Director of the Virginia Retina Center in Warrenton, VA and Clinical Professor of Ophthalmology at the George Washington University in Washington DC. For patients struggling with DME, it's important to have easy access to information on the disease and treatment options.”
MicroPulse Laser Therapy is a retina-sparing solution for the treatment of DME. MicroPulse Laser Therapy also can be used in conjunction with drug therapy, allowing complete and optimized management of DME without laser-induced retinal damage.
About MicroPulse Technology
MicroPulse is a tissue-sparing laser delivery therapy that works by electronically “chopping” the laser emission into trains of microsecond pulses. This enhances the physician's ability to more precisely control the laser effects on target tissues, offering the potential for ocular treatment with less collateral effects than conventional laser treatments.